Moving from the lab to the clinic
by Heather Blumenthal
It’s one thing to be known among your friends for your famous boeuf bourguignon recipe. It’s another thing entirely to open your own restaurant based on that recipe. All of a sudden you need to deal with things like quality of ingredients, scaling up that favourite recipe to serve multiple times a night, and making sure that each serving is of consistently high standards and won’t accidently make a customer sick.
It’s much the same thing with T cells, a type of white blood cell that’s particularly good at attacking tumors. But taking them out of the lab and into the clinic takes a lot of work – work that the BC Cancer Agency’s Dr. Brad Nelson is focused on right now.
|
|
|
| FUNDING OPPORTUNITIES |
|
|
BioCanRx funding opportunities:
BioCanRx Rolling Open-Call
Stay tuned for deadline details
Other funding opportunities currently available:
Ontario Research Fund - Research Excellence (ORF-RE) program
The Ontario Ministry of Research, Innovation and Science (MRIS)
Deadline for NOIs: May 2, 2017
Full application deadline: September 25, 2017
|
|
Training Programs:
HQP Travel Awards – travel support to attend external training and educational events identified by HQP (i.e. conferences, workshops, etc.)
Funding: Up to $1,000 CAD
Deadline: Various throughout the year, closest one: June 9, 2017
Lab Exchanges – travel support for knowledge and technology exchange between research labs or industry
Funding: Up to $3,000
Deadline: Various throughout the year
Seminars/Workshops:
Media Relations: How to get your story into the press
March 23, 2017 from 1:00 - 2:00 PM EST
Part of the SMRTS Seminars Program for professional skills development, this seminar will be hosted by the Ontario Institute for Regenerative Medicine.
|
|
|
Speakers Set for 2017 Summit for Cancer Immunotherapy
The keynote speakers are set for BioCanRx’s 2017 Summit for Cancer Immunotherapy (Summit4CI) this June 25 – 28, in Gatineau, Quebec. We are pleased to have Robert Andtbacka (Huntsman Cancer Institute) and Stanley Riddell (Fred Hutchinson Cancer Research Center) deliver the opening keynote presentations on the evening of Sunday, June 25 and Dr. Jeffrey Hoch (UC Davis) deliver the closing keynote on Wednesday, June 28.
Summit4CI will bring together more than 250 leading scientists, clinicians, students and economists with representatives from industry, patient groups, charities and government. The Summit will explore the latest progress in cancer biotherapeutics from scientific, clinical, industry and patient perspectives through internationally recognized speakers, scientific presentations, poster sessions, panel discussions and networking opportunities. Here are some of the plenary session topics scheduled for Summit4CI:
- The Microbiome
- Novel Preclinical Models & In Vitro Screening Platforms
- Antibodies & Antibody-like Molecules
- Innate Immunity
- Oncolytic Viruses & Viral Vaccines
- Adoptive Cell Therapy: Beyond Melanoma
We hope to see you at Summit4CI being held this year in the national capital region to celebrate Canada's 150th birthday! Check out the Summit website for full program details, additional distinguished speakers, registration and sponsorship information: http://www.cancersummit.ca/
|
|
Summit for Cancer Immunotherapy 2017
Early Bird Registration
Summit registration is open - register before April 19, 2017, for the Early Bird Discount
Final Registration Deadline: May 17, 2017
HQP Career Development Day
Check out the agenda for this HQP training workshop
Sunday, June 25, 2017
Travel Award Competition - Closed: Primary authors will notified of the competition results by Friday, March 31, 2017
Abstract Submissions
Final deadline: May 3, 2017
Other upcoming events:
Innovative approaches to optimal cancer care in Canada
CPAC | April 7-8, 2017
Vaccine Innovation Conference
BIOTECanada | May 10, 2017
Science Odyssey - Ten days of discovery and innovation
May 12 to 21, 2017
ARCC Conference 2017
May 25 to 26, 2017 | Toronto, ON
CDRD Symposium: Novel Strategies in Cancer Immunotherapy
May 26, 2017 | Vancouver, BC
|
|
|
|
Dr. John Bell, BioCanRx's Scientific Director and Senior Scientist at The Ottawa Hospital spoke on oncolytic viruses to promote anticancer activity at the #CellCANforum
|
|
|
|
Working with Patients to Inform Early-phase Cancer Clinical Trial Design
|
|
March 8, 2017 - This successful workshop is in thanks of the partnerships between BioCanRx, CellCAN and the Ottawa Hospital Research Institute. The workshop received positive feedback from participants who were in agreement that the learning objectives had been met. This learning opportunity highlighted BioCanRx’s first push to incorporating the patient voice into its research program. Attendees included BioCanRx highly qualified personnel, Cancer Stakeholder Alliance members, and other patient-focused organizations. Presenting were Network investigators Manoj Lalu and Justin Presseau, along with patient Anne Lyddiatt and SPOR Program Facilitator Zarah Monfaredi, covering topics such as what patient-oriented research is, how it is used to inform and impact clinical trials currently, and how BioCanRx intends to conduct patient-oriented research to inform cancer clinical trial design of the first made-in-Canada CAR-T therapy.
Stay tuned for more discussions in patient-oriented research at our Summit for Cancer Immunotherapy in June 2017!
|
|
|
Network members: Feature your research here by sending us a link to your recent publication!
|
|
|
A message from BioCanRx's President and CEO on International Women's Day.
|
|
|
|
